Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 22 March 2016 |
| Author/s |
author: Jonathan A Ledermann Alan V. Boddy Nicola Curtin Gordon C. Jayson David Jamieson |
| Publication date | March 22, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |